QUARTERLY FINANCIAL DATA (Tables)

12 Months Ended

Dec. 31, 2016

Quarterly Financial Data [Abstract]

Schedule of Quarterly Financial Information

	For the Year Ended December 31, 2015
	First Quarter (Unaudited)			Second Quarter (Unaudited)			Third Quarter (Unaudited)			Fourth Quarter (Unaudited)
Consolidated Statements of Operations and Comprehensive Income / Loss Data:
Net revenues	$	126,133		$	166,834		$	117,322		$	195,552
Cost of revenues	98,828			101,229			85,832			116,654
Operating (loss) / income	(17,239		)	36,441			28,853			46,528
(Loss) / income from continuing operations	(70,243		)	(11,669		)	(21,510		)	1,137
(Loss) / income from discontinued operations, net of tax	(3,288		)	2,684			(265		)	(12,418		)
Net loss	(73,531		)	(8,985		)	(21,775		)	(11,281		)
Net loss attributable to CME Ltd.	(73,274		)	(8,678		)	(21,522		)	(11,427		)
Net loss per share:
Basic EPS	$	(0.53	)	$	(0.09	)	$	(0.18	)	$	(0.11	)
Effect of dilutive securities	—			—			—			—
Diluted EPS	$	(0.53	)	$	(0.09	)	$	(0.18	)	$	(0.11	)

Selected quarterly financial data for the years ended December 31, 2016 and 2015 is as follows:

	For the Year Ended December 31, 2016
	First Quarter (Unaudited)			Second Quarter (Unaudited)			Third Quarter (Unaudited)			Fourth Quarter (Unaudited)
Consolidated Statements of Operations and Comprehensive Income / Loss Data:
Net revenues	$	129,000		$	175,206		$	126,706		$	207,101
Cost of revenues	97,777			104,962			91,141			119,946
Operating income	7,763			43,891			8,384			51,551
(Loss) / income from continuing operations	(40,694		)	(141,249		)	(19,823		)	21,169
Net (loss) / income	(40,694		)	(141,249		)	(19,823		)	21,169
Net (loss) / income attributable to CME Ltd.	(40,435		)	(141,317		)	(19,627		)	21,088
Net (loss) / income per share:
Basic EPS	$	(0.31	)	$	(0.98	)	$	(0.14	)	$	0.07
Effect of dilutive securities	—			—			—			(0.01		)
Diluted EPS	$	(0.31	)	$	(0.98	)	$	(0.14	)	$	0.06